Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of BMS-582949 treatment on gene expression in osteoclasts

ABSTRACT: Effect of BMS-582949 treatment on gene expression in osteoclasts

PROVIDER: PRJNA1051041 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27173702_1.fastq.gz	Fastqsanger.gz
	SRR27173702_2.fastq.gz	Fastqsanger.gz
	SRR27173703_1.fastq.gz	Fastqsanger.gz
	SRR27173703_2.fastq.gz	Fastqsanger.gz
	SRR27173704_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Effect of NVP-BHG712 treatment on gene expression of BMMs differentiating into osteoclasts.

Project description:Effect of NVP-BHG712 treatment on gene expression of BMMs differentiating into osteoclasts.

| PRJNA1086539 | ENA

Effect of BMS-582949 treatment on gene expression in osteoclasts

Project description:Controlling excessive osteoclastic activity is a promising strategy for many bone disease treatments. Here we report that 10 μM BMS-582949, a clinical p38α inhibitor,dromatically suppresses the osteoclast differentiation in vitro. Our results provide a evidence that BMS-582949 could be a candicdate drug for the therapy of osteolytic diseases.

2024-02-29 | GSE249860 | GEO

Effect of embryo lysates treatment on gene expression.

Project description:Effect of embryo lysates treatment on gene expression.

| PRJNA1104627 | ENA

Effect of genetic deletion of Slc37a2 on gene expression of mouse bone marrow macrophage-derived osteoclasts

Project description:To investigate the mechanism(s) by which Slc37a2 regulates osteoclasts, we performed gene expression profiling analysis using data obtained from RNA-seq of osteoclasts derived from wild-type and Slc37a2-knockout mice (C57BL/6N-SLC37A2 tm2a(KOMP)Wtsi)

2023-01-03 | GSE219216 | GEO

Expression profile of osteoclasts treated with bisphosphonates

Project description:Bisphosphonates are the mainstay of therapy worldwide for osteoporosis. They inhibit the activities of the osteoclasts, the bone resorption cells. While bisphosphonates are known to block farnesyl pyrophsophate synthase to exert their anti-resorptive action, the detailed mechanism is not well understood. Examining the change in expression profile before and after bisphosphonate treatment in the osteoclasts might shed some light on the biological pathways that are perturbed. Osteoclastic precursor cells were treated with (or without) bisphosphonates (alendronate or risedronate) during their differentiation into mature osteoclasts.

2014-11-06 | E-GEOD-63009 | biostudies-arrayexpress

Effect of Hairy and Enhancer of Split 1 (HES1) activation on gene expression of mature osteoclasts

Project description:To investigate the role of HES1 in osteoclast differentiation and function, bone marrow-derived macrophages (BMMs) were derived from CtskCre/WT;RosaHes1 and control (Rosa[STOP]Hes1 ) mice and were differentiated into mature osteoclasts. We then performed gene expression profiling analysis using data obtained from RNA-seq of conrol and HES1-overexpressing osteoclasts.

2022-07-01 | GSE207120 | GEO

Sex differential gene expression in macrophages and osteoclasts

Project description:Sex differential gene expression in macrophages and osteoclasts

| PRJNA896199 | ENA

Effect of Parathyroid Hormone Analog Treatment on Gene Expression

Project description:Effect of Parathyroid Hormone Analog Treatment on Gene Expression

| PRJNA751605 | ENA

Effect of TIMP1 treatment on human VSMC gene expression

Project description:Effect of TIMP1 treatment on human VSMC gene expression

| PRJNA1034045 | ENA

Effect of TAM_MK-8931 treatment on TAMs gene expression

Project description:Effect of TAM_MK-8931 treatment on TAMs gene expression